Both compounds can be distinguished from typical D 2 agonists, however, because they do not cause behavioral signs associated with activation of either normosensitive or supersensitive ...

Bromocriptine is a sympatholytic D2-dopamine agonist that has been approved for the treatment of type 2 diabetes. Based on animal and human studies, timed bromocriptine administration within 2 h ...